Interstitial Lung Diseases: Clinical Trials

1 trial for Interstitial Lung Diseases, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Active not recruiting 1

Follow Interstitial Lung Diseases: new trials by email Literature Review of Interstitial Lung Diseases trials Research Report on Interstitial Lung Diseases

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Test Whether Nerandomilast Helps People With Lung Fibrosis Related to Rheumatic Diseases
Nerandomilast, Placebo matching nerandomilast - Interstitial Lung Diseases, Systemic Autoimmune Rheumatic Diseases Associated Interstitial Lung Diseases
Phase 3Active not recruitingBoehringer Ingelheim4142025-09-132026-10-28

Narrower conditions

Lung Diseases, Interstitial (1)

Broader conditions

Lung Diseases (1)  ·  Respiratory Tract Diseases (1)

Sponsors

Boehringer Ingelheim (1)

Countries

Australia (1)  ·  Austria (1)  ·  China (1)  ·  France (1)  ·  Germany (1)  ·  Italy (1)  ·  Japan (1)  ·  Mexico (1)  ·  Netherlands (1)  ·  Norway (1)  ·  Puerto Rico (1)  ·  South Korea (1)  ·  Spain (1)  ·  Switzerland (1)  ·  United Kingdom (1)